Lupus isn’t caused by a single thing you caught or did. It develops when a combination of genetic susceptibility, hormonal factors, and environmental triggers converge to push the immune system into attacking the body’s own tissues. About 204,000 people in the United States have systemic lupus erythematosus (SLE), the most common form, and 9 out of 10 of them are women. Understanding how these factors layer on top of each other is the key to understanding how someone “gets” lupus.
Genetics Load the Gun
Lupus runs in families, but it doesn’t follow a simple inheritance pattern like eye color. Instead, dozens of genes each contribute a small amount of risk. The most significant cluster sits on chromosome 6, in a region that controls how immune cells distinguish the body’s own proteins from foreign invaders. People who carry certain variants of these immune-signaling genes, particularly those known as HLA-DR2 and HLA-DR3, face a higher likelihood of developing lupus across all ethnic backgrounds. Other variants, like HLA-DR7 in Asian populations, appear to be protective.
Having a parent or sibling with lupus increases your risk, but it doesn’t make the disease inevitable. Most people with lupus-associated gene variants never develop it. What these genes do is create a baseline where the immune system is slightly more reactive, slightly more prone to confusion between “self” and “threat.” That baseline needs a push from something else to tip into disease.
Hormones Explain the Gender Gap
The overwhelming female prevalence of lupus points directly to estrogen. Before puberty, the female-to-male ratio is about 3 to 1. During the reproductive years (roughly ages 15 to 44), it jumps to 10 to 1. After menopause, it drops back to about 8 to 1. That pattern tracks almost perfectly with estrogen levels across a woman’s lifespan.
Lupus patients tend to have higher estrogen levels than healthy people of the same age, and those levels correlate with disease severity. Estrogen amplifies certain immune functions: it influences how T cells behave and ramps up antibody production in B cells. It also promotes the activation of immune cells called monocytes. This doesn’t mean estrogen causes lupus on its own, but it creates a hormonal environment where an already genetically primed immune system is more likely to go haywire. Women of childbearing age face the highest risk for exactly this reason.
Environmental Triggers That Push the Immune System Over
For someone with genetic susceptibility and the right hormonal conditions, an environmental exposure can be the final catalyst. Several triggers have strong evidence behind them.
Ultraviolet Light
Sun exposure is one of the most well-established triggers. UV radiation has a paradoxical dual effect on the immune system: it suppresses some responses while stimulating others. This disruption can alter how the body responds to infections and increase the production of antibodies that mistakenly target the body’s own cells. Many people with lupus experience their first flare or their diagnosis after significant sun exposure.
Silica Dust
Occupational exposure to crystalline silica, the fine quartz particles found in sand, rock, and soil, carries a meaningful risk. Workers in construction, mining, and agriculture face the greatest exposure. A large study in the southeastern United States found that medium to high levels of silica dust exposure doubled to quadrupled the odds of developing lupus, and this association held across sex, race, and education levels. The intensity of exposure matters more than the total amount accumulated over a lifetime.
Smoking
Current smoking modestly increases lupus risk, with studies showing about a 50% higher chance compared to nonsmokers. Interestingly, past smoking (having quit before diagnosis) shows no increased risk, suggesting that active tobacco exposure is what matters. Tobacco smoke disrupts immune function in multiple ways, altering the balance of inflammatory signaling and reducing the activity of natural killer cells that help regulate immune responses.
A Common Virus Plays a Surprising Role
The Epstein-Barr virus (EBV), which causes mono and infects roughly 95% of adults at some point, appears to be a direct contributor to lupus. In healthy people, about 1 in 10,000 B cells (the immune cells that produce antibodies) carry a dormant EBV infection. In lupus patients, that number rises to about 1 in 400, a 25-fold increase.
Research from Stanford Medicine has shown how this works. EBV hides inside B cells and stays mostly inactive, but it occasionally produces a viral protein that reprograms the infected cell. These reprogrammed B cells then activate other, previously dormant B cells, including ones that were designed to stay quiet because they react to the body’s own tissues. Once awakened, these rogue B cells pump out antibodies that target proteins and DNA inside the nuclei of normal cells throughout the body. These “antinuclear antibodies” are the hallmark of lupus, and they cause the widespread, seemingly random tissue damage that characterizes the disease.
Because virtually every cell in the body has a nucleus, these misguided antibodies can attack skin, joints, kidneys, the brain, and other organs with no predictable pattern.
How Gene Expression Changes Without Changing Genes
Between your DNA and its actual behavior sits a layer of chemical switches that determine which genes are active and which stay silent. In lupus patients, researchers have found that the switches controlling inflammation-related genes are stuck in the “on” position. Specifically, genes that respond to interferon, a protein the body uses to fight infections, lose the chemical tags that normally keep them in check. The result is that the immune system becomes hypersensitive to interferon, amplifying inflammation far beyond what’s appropriate.
This may explain why lupus can develop gradually. Some studies have found mildly elevated interferon levels in healthy relatives of lupus patients, suggesting a genetic tendency. If that chronic, low-level interferon exposure slowly strips away the chemical “off switches” on inflammatory genes over years, it could create a self-reinforcing cycle where the immune system becomes progressively more reactive until it crosses a threshold into full disease.
Certain Medications Can Trigger Lupus
Drug-induced lupus is a distinct condition that mimics SLE but resolves after stopping the medication responsible. The most common culprits include hydralazine (a blood pressure drug), procainamide and quinidine (heart rhythm medications), isoniazid (a tuberculosis drug), diltiazem (a calcium channel blocker), and minocycline (an antibiotic). Some newer immunotherapy drugs can also cause it.
These medications trigger the production of antibodies against proteins in cell nuclei, similar to what happens in regular lupus but through a different mechanism. The critical difference is that drug-induced lupus typically clears up within days to months after the offending medication is stopped. A skin-only variant has been linked to certain diuretics and antifungal medications, and it also resolves after discontinuation.
Who Faces the Highest Risk
Lupus does not affect all populations equally. Of the estimated 204,000 Americans with SLE, about 184,000 are female and 20,000 are male. Black and American Indian/Alaska Native women are two to three times more likely to develop lupus than white women. Hispanic and Asian populations also face elevated risk compared to white populations.
These disparities reflect a combination of genetic differences in immune-related genes across ancestral populations, varying levels of environmental exposures, and socioeconomic factors that influence both exposure to triggers and access to early diagnosis. The peak risk window is women of childbearing age, 15 to 44, where the convergence of genetic susceptibility, high estrogen levels, and cumulative environmental exposures creates the conditions most likely to trigger the disease.
No genetic test currently exists that can predict whether someone will develop lupus, and no proven prevention strategy can guarantee protection. For people with a family history, practical steps like consistent sun protection and avoiding smoking address two of the modifiable risk factors with the strongest evidence behind them.